BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

Evaluation of clinical and laboratory parameters in sepsis patients with elevated il-6 levels: an observational analysis

Authors:Sunil Kumar Nanda*, Reba Kanungo, Nayyar Iqbal , Kandasamy Ravichandran
Int J Biol Med Res. 2025; 16(3): 8112-8116  |  PDF File

Abstract

Background: Elevated levels of interleukin-6 (IL-6) are often indicative of systemic inflammation and have been linked to severe clinical outcomes in various medical conditions. This study aims to evaluate the demographic, clinical, and laboratory characteristics of sepsis patients with elevated IL-6 levels in a tertiary care setting and to investigate the correlation between IL-6 levels and clinical outcomes. Methods: This observational study included 70 sepsis patients. Data on demographics, clinical features, and laboratory parameters were collected and analyzed using descriptive statistics, frequency distributions, and comparative analyses. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Results: The study population had a mean age of 54.73 years, with a predominance of males (62.9%). The mean IL-6 level was 122.22 pg/ml, with 34.3% of patients in the High and Very High IL-6 categories. Escherichia coli was the most frequently isolated pathogen. Patients with prolonged hospital stays (>14 days) had significantly elevated IL-6 levels. Elevated IL-6 levels were also associated with higher rates of organ failure and increased mortality. Conclusion: Elevated IL-6 levels are strongly associated with adverse clinical outcomes, including prolonged hospital stay and multi-organ failure. Early identification and targeted interventions in patients with elevated IL-6 levels may improve prognosis and reduce healthcare burden.